FRCPath Haem Part 1 MCQ-Oncology 46
- amirhayat2527
- Sep 3
- 0 min read
Updated: Sep 4
In CD20-positive PTLD, if there is inadequate response after 4 weekly rituximab doses, BSH recommends next:
Bendamustine Rituximab
Pola-R-CHP
R-CHOP
Switch to Brentuximab
Correct Answer: R-CHOP as per BSH Guidelines